Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 139.19% is 24% above its 5-year average of 111.91%, near the high end of its 5-year range (35.99%–183.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.56% below its 12-month average of 150.58%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 139.19%.
DEBT TO ASSETS RATIO
139.19%
DEBT TO ASSETS RATIO AVG TTM
150.58%
DEBT TO ASSETS RATIO AVG 3Y
154.79%
DEBT TO ASSETS RATIO AVG 5Y
111.91%
DEBT TO ASSETS RATIO AVG 10Y
99.59%
DEBT TO ASSETS RATIO AVG 15Y
78.72%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.56%
CURRENT VS 3Y AVG
-10.08%
CURRENT VS 5Y AVG
+24.37%
CURRENT VS 10Y AVG
+39.77%
CURRENT VS 15Y AVG
+76.81%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 651 covered companies
CURRENT VS SECTOR MEDIAN
+139088.72%
vs the sector median at left
Ironwood Pharmaceuticals, Inc.
Market Cap
$600.01M
Debt to Assets Ratio
139.19%
TTM Avg
150.58%
3Y Avg
154.79%
5Y Avg
111.91%
Market Cap
$600.51M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$609.24M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$585.62M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$622.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$568.99M
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$567.12M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $600.01M | 139.19% | 150.58% | 154.79% | 111.91% |
| Fulgent Genetics, Inc. (FLGT)vs › | $600.51M | 0.01% | N/A | N/A | N/A |
| AngioDynamics, Inc. (ANGO)vs › | $609.24M | 0.00% | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $585.62M | 0.18% | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $622.01M | 0.00% | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $568.99M | 0.45% | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | 0.01% | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $563.68M | 0.16% | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $637.30M | 0.01% | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $561.45M | 0.00% | N/A | N/A | N/A |
Debt/Assets
139.2%
Debt/Equity
N/A
Current Ratio
6.06
Interest Coverage
3.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 139.19% |
| 2026-03-31 | 137.46% |
| 2025-12-31 | 150.62% |
| 2025-09-30 | 151.05% |
| 2025-06-30 | 174.57% |
| 2025-03-31 | 183.09% |
| 2024-12-31 | 170.84% |
| 2024-09-30 | 157.85% |
| 2024-06-30 | 161.84% |
| 2024-03-31 | 157.34% |
| 2023-12-31 | 151.90% |
| 2023-09-30 | 141.33% |
| 2023-06-30 | 135.23% |
| 2023-03-31 | 35.99% |
| 2022-12-31 | 37.79% |
| 2022-09-30 | 39.99% |
| 2022-06-30 | 42.65% |
| 2022-03-31 | 49.55% |
| 2021-12-31 | 42.22% |
| 2021-09-30 | 43.56% |
| 2021-06-30 | 46.12% |
| 2021-03-31 | 76.60% |
| 2020-12-31 | 81.13% |
| 2020-09-30 | 91.08% |
| 2020-06-30 | 99.82% |
| 2020-03-31 | 108.15% |
| 2019-12-31 | 107.07% |
| 2019-09-30 | 136.96% |
| 2019-06-30 | 136.86% |
| 2019-03-31 | 137.01% |
| 2018-12-31 | 124.66% |
| 2018-09-30 | 98.24% |
| 2018-06-30 | 65.86% |
| 2018-03-31 | 70.69% |
| 2017-12-31 | 66.07% |
| 2017-09-30 | 63.41% |
| 2017-06-30 | 55.73% |
| 2017-03-31 | 55.53% |
| 2016-12-31 | 52.52% |
| 2016-09-30 | 51.70% |
| 2016-06-30 | 53.86% |
| 2016-03-31 | 62.91% |
| 2015-12-31 | 61.62% |
| 2015-09-30 | 62.39% |
| 2015-06-30 | 58.54% |
| 2015-03-31 | 57.22% |
| 2014-12-31 | 53.17% |
| 2014-09-30 | 51.63% |
| 2014-06-30 | 48.23% |
| 2014-03-31 | 42.66% |
| 2013-12-31 | 64.15% |
| 2013-09-30 | 54.99% |
| 2013-06-30 | 45.58% |
| 2013-03-31 | 53.86% |
| 2012-12-31 | 0.25% |
| 2012-09-30 | 0.26% |
| 2012-06-30 | 0.31% |
| 2012-03-31 | 0.28% |
| 2011-12-31 | 0.31% |
| 2011-09-30 | 0.32% |
| 2011-06-30 | 0.31% |
| 2011-03-31 | 0.31% |
| 2010-12-31 | 0.20% |
| 2010-09-30 | 0.21% |
| 2010-06-30 | 0.92% |
| 2010-03-31 | 0.92% |
| 2009-12-31 | 2.05% |
| 2009-09-30 | 2.28% |
| 2008-12-31 | 1.51% |
